Stevanato Group S.p.A. Stock (NYSE:STVN)
Previous Close
$22.64
52W Range
$16.56 - $29.11
50D Avg
$20.68
200D Avg
$20.48
Market Cap
$6.03B
Avg Vol (3M)
$362.68K
Beta
0.52
Div Yield
$0.06 (0.26%)
STVN Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
STVN Performance
Revenue Breakdown
Peer Comparison
| Ticker | Company |
|---|---|
| ATR | AptarGroup, Inc. |
| RMD | ResMed Inc. |
| ICUI | ICU Medical, Inc. |
| NVST | Envista Holdings Corp |
| MMSI | Merit Medical Systems, Inc. |
| AKYA | Akoya Biosciences, Inc. |
| COO | The Cooper Companies, Inc. |
| ATRC | AtriCure, Inc. |
| WST | West Pharmaceutical Services, Inc. |
| TFX | Teleflex Incorporated |
| HAE | Haemonetics Corporation |
| ANGO | AngioDynamics, Inc. |
| XRAY | DENTSPLY SIRONA Inc. |
| ALC | Alcon Inc. |